MRD-话题@MedSci

#MRD#

21篇内容 | 3484人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1411040, encodeId=2c4c1411040cb, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Acta Neuropathologica: 原发性错配修复缺陷型IDH突变体星形细胞瘤（PMMRDIA）是一种预后不良的独特类型, objectType=article, longId=203736, objectId=8b6e203e36d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b6e203e36d5, replyNumber=0, likeNumber=79, createdTime=2020-11-27, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b6e203e36d5, moduleTitle=Acta Neuropathologica: 原发性错配修复缺陷型IDH突变体星形细胞瘤（PMMRDIA）是一种预后不良的独特类型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b6e203e36d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411039, encodeId=ce8b141103902, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=JAMA Oncol：急性髓性白血病患者中MRD与生存结果的关联, objectType=article, longId=202343, objectId=577f202343c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=577f202343c1, replyNumber=0, likeNumber=64, createdTime=2020-10-23, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=577f202343c1, moduleTitle=JAMA Oncol：急性髓性白血病患者中MRD与生存结果的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=577f202343c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411038, encodeId=cc82141103836, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Blood：诱导缓解早期MRD水平对ALL患儿采用低强度化疗预后的影响, objectType=article, longId=202013, objectId=d7a52020132d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7a52020132d, replyNumber=0, likeNumber=90, createdTime=2020-10-13, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7a52020132d, moduleTitle=Blood：诱导缓解早期MRD水平对ALL患儿采用低强度化疗预后的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7a52020132d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411037, encodeId=c1fe141103ee1, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Blood：Getuzumab ozogamicin治疗对NPM1突变AML患者MRD和复发风险的影响, objectType=article, longId=200012, objectId=052a20001262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=052a20001262, replyNumber=0, likeNumber=149, createdTime=2020-08-30, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=052a20001262, moduleTitle=Blood：Getuzumab ozogamicin治疗对NPM1突变AML患者MRD和复发风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=052a20001262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411036, encodeId=0b1b1411036cf, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Blood：分子MRD状态对患者alloSCT后预后的预测价值, objectType=article, longId=186296, objectId=2eed1862968b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2eed1862968b, replyNumber=0, likeNumber=88, createdTime=2020-01-16, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2eed1862968b, moduleTitle=Blood：分子MRD状态对患者alloSCT后预后的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2eed1862968b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411035, encodeId=4788141103564, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Blood：MRD检测对t(8；21)(q22；q22.1)型AML患者复发风险和总体存活率的预测价值, objectType=article, longId=180114, objectId=c37518011416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c37518011416, replyNumber=0, likeNumber=0, createdTime=2019-09-28, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c37518011416, moduleTitle=Blood：MRD检测对t(8；21)(q22；q22.1)型AML患者复发风险和总体存活率的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c37518011416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411034, encodeId=77fc1411034a7, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Blood：MRD阳性的AML患者也可进行异体干细胞移植, objectType=article, longId=177374, objectId=2bfc1e7374a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bfc1e7374a3, replyNumber=0, likeNumber=88, createdTime=2019-08-11, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bfc1e7374a3, moduleTitle=Blood：MRD阳性的AML患者也可进行异体干细胞移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bfc1e7374a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411033, encodeId=d05214110339e, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Blood：alloHCT前进行NGS-MRD分析，可较准确预测AML患者预后, objectType=article, longId=148500, objectId=a6fd14850017, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6fd14850017, replyNumber=0, likeNumber=91, createdTime=2018-09-10, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6fd14850017, moduleTitle=Blood：alloHCT前进行NGS-MRD分析，可较准确预测AML患者预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6fd14850017)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411032, encodeId=44901411032b0, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Blincyto适应症扩容：MRD阳性ALL, objectType=article, longId=134487, objectId=05e813448ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05e813448ebe, replyNumber=0, likeNumber=95, createdTime=2018-04-09, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05e813448ebe, moduleTitle=Blincyto适应症扩容：MRD阳性ALL, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05e813448ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411031, encodeId=3f7f141103152, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Blood：急性髓性白血病的可检测残余病灶（MRD，又称微小残留病灶）的检测、临床应用。, objectType=article, longId=126548, objectId=e6d5126548d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6d5126548d0, replyNumber=0, likeNumber=97, createdTime=2018-01-17, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6d5126548d0, moduleTitle=Blood：急性髓性白血病的可检测残余病灶（MRD，又称微小残留病灶）的检测、临床应用。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6d5126548d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411030, encodeId=ed9c14110308f, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=Cancer：在年轻的急性髓系白血病（AML）患者中，多参数流式细胞术对微小残留病变（MRD）的预后研究, objectType=article, longId=78937, objectId=dd4ee8937c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd4ee8937c1, replyNumber=0, likeNumber=69, createdTime=2016-09-30, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd4ee8937c1, moduleTitle=Cancer：在年轻的急性髓系白血病（AML）患者中，多参数流式细胞术对微小残留病变（MRD）的预后研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd4ee8937c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411029, encodeId=a3c61411029aa, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=JCO：ALL患儿可根据MRD情况选择合适的化疗, objectType=article, longId=71338, objectId=c7a4e1338eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7a4e1338eb, replyNumber=0, likeNumber=94, createdTime=2016-06-22, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7a4e1338eb, moduleTitle=JCO：ALL患儿可根据MRD情况选择合适的化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7a4e1338eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411028, encodeId=2a651411028d3, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=EHA 2013：LymphoSIGHT检出急性淋巴细胞白血病（ALL）微小残留病（MRD）优于传统方法, objectType=article, longId=20757, objectId=f2c720e57a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2c720e57a6, replyNumber=0, likeNumber=94, createdTime=2013-07-03, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2c720e57a6, moduleTitle=EHA 2013：LymphoSIGHT检出急性淋巴细胞白血病（ALL）微小残留病（MRD）优于传统方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2c720e57a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1411027, encodeId=6d86141102e97, content=<a href='/topic/show?id=a649121941c' target=_blank style='color:#2F92EE;'>#MRD#</a>, objectTitle=MRDTI：检测冠脉内血栓添新法, objectType=article, longId=2905, objectId=87662905bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87662905bd, replyNumber=0, likeNumber=130, createdTime=2011-07-24, rootId=0, userName=yaanren, userId=3c6a2793900, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87662905bd, moduleTitle=MRDTI：检测冠脉内血栓添新法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87662905bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MRD

2020-05-29

智慧医人 (审核中...)

前往app查看评论内容

#MRD#

Acta Neuropathologica: 原发性错配修复缺陷型IDH突变体星形细胞瘤（PMMRDIA）是一种预后不良的独特类型

2020-11-27

yaanren (审核中...)

前往app查看评论内容

#MRD#

JAMA Oncol：急性髓性白血病患者中MRD与生存结果的关联

2020-10-23

yaanren (审核中...)

前往app查看评论内容

#MRD#

Blood：诱导缓解早期MRD水平对ALL患儿采用低强度化疗预后的影响

2020-10-13

yaanren (审核中...)

前往app查看评论内容

#MRD#

Blood：Getuzumab ozogamicin治疗对NPM1突变AML患者MRD和复发风险的影响

2020-08-30

yaanren (审核中...)

前往app查看评论内容

#MRD#

Blood：分子MRD状态对患者alloSCT后预后的预测价值

2020-01-16

yaanren (审核中...)

前往app查看评论内容

#MRD#

Blood：MRD检测对t(8；21)(q22；q22.1)型AML患者复发风险和总体存活率的预测价值

2019-09-28

yaanren (审核中...)

前往app查看评论内容

#MRD#

Blood：MRD阳性的AML患者也可进行异体干细胞移植

2019-08-11

yaanren (审核中...)

前往app查看评论内容

#MRD#

Blood：alloHCT前进行NGS-MRD分析，可较准确预测AML患者预后

2018-09-10

yaanren (审核中...)

前往app查看评论内容

#MRD#

Blincyto适应症扩容：MRD阳性ALL

2018-04-09

yaanren (审核中...)

前往app查看评论内容

#MRD#

Blood：急性髓性白血病的可检测残余病灶（MRD，又称微小残留病灶）的检测、临床应用。

2018-01-17

yaanren (审核中...)

前往app查看评论内容

#MRD#

Cancer：在年轻的急性髓系白血病（AML）患者中，多参数流式细胞术对微小残留病变（MRD）的预后研究

2016-09-30

yaanren (审核中...)

前往app查看评论内容

#MRD#

JCO：ALL患儿可根据MRD情况选择合适的化疗

2016-06-22

yaanren (审核中...)

前往app查看评论内容

#MRD#

EHA 2013：LymphoSIGHT检出急性淋巴细胞白血病（ALL）微小残留病（MRD）优于传统方法

2013-07-03

yaanren (审核中...)

前往app查看评论内容

#MRD#

MRDTI：检测冠脉内血栓添新法

2011-07-24

科室
- - 订阅+
  - 更多科室
工具
服务